Yingxian Liu1 article listing Yingxian Liu in Nature Communications, indexed by Paperzzz from Crossref and OSF.Zanubrutinib-rituximab followed by shortened chemoimmunotherapy as frontline treatment for mantle cell lymphoma (CHESS): a phase II trial Nature Communications